Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02469701
Title BrUOG 317: Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors howard safran
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.